Virginia 2026 Regular Session

Virginia House Bill HB813

Introduced
1/13/26  
Refer
1/13/26  
Report Pass
2/5/26  
Engrossed
2/10/26  
Engrossed
2/11/26  
Refer
2/12/26  
Report Pass
2/23/26  
Enrolled
3/3/26  
Chaptered
4/6/26  

Caption

An Act to amend and reenact ยงยง 38.2-3407.20 and 38.2-3418.7 of the Code of Virginia, relating to health insurance; application of cost-sharing prohibitions.

Impact

The bill modifies existing statutes to eliminate cost-sharing requirements associated with health plans, particularly in preventive care scenarios. This change is aimed at increasing access to essential health screenings, which is crucial for early detection and treatment of prostate cancer. It mandates that insurers must provide coverage for specified preventive services without deductibles or copayments, thereby alleviating financial barriers that might prevent individuals from seeking necessary medical attention.

Summary

House Bill 813 focuses on the application of cost-sharing prohibitions in health insurance and mandates specific coverage requirements related to prostate cancer screening. The bill aims to ensure that individuals receiving healthcare services under any health plan are not subject to cost-sharing fees when accessing preventive services, particularly for prostate cancer screenings. This includes provisions for individuals aged 50 and over, and those 40 and over at high risk, ensuring coverage without out-of-pocket costs for necessary screenings.

Sentiment

The reception of HB 813 has been largely positive among health advocates and organizations focused on cancer awareness, who argue that eliminating cost-sharing for preventive services will significantly improve health outcomes. However, there is a recognition of the need for financial sustainability within the health insurance sector, as some stakeholders express concerns about the implications of such mandates on insurance premium costs and the overall economic feasibility of these requirements for insurers.

Contention

Some key points of contention surrounding the bill include debates over the balance between ensuring patient access to preventive care and the economic impacts of increased state mandates on health insurers. Critics express concerns regarding the potential for higher premiums as a result of these cost-sharing prohibitions. Additionally, there is discourse on how to ensure that the provisions for preventive care do not lead to disqualification from high-deductible health plans that might provide broader healthcare options for individuals.

Companion Bills

No companion bills found.

Previously Filed As

VA SB1078

Health insurance; cost-sharing, pharmacy benefits managers, compensation and duties, civil penalty.

VA HB2773

Health insurance; cost-sharing, pharmacy benefits managers, compensation and duties, civil penalty.

VA HB1041

Health insurance; cost-sharing, pharmacy benefits managers' compensation and duties, civil penalty.

VA HB1670

Health insurance; cost-sharing for epinephrine injectors.

VA HB1828

Health insurance; cost sharing for breast examinations.

VA SB1436

Health insurance; cost sharing for breast examinations.

VA SB1238

Health insurance; cost sharing for breast examinations.

VA HB230

Health insurance; cost sharing for breast examinations.

VA HB2611

Health insurance; coverage for cancer follow-up testing, report.

VA HB1347

Health insurance; coverage for autism spectrum disorder, cost-sharing requirements prohibited.

Similar Bills

No similar bills found.